Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis

Duan, Wenlan; Paka, Latha; Pillarisetti, Sivaram
January 2005
Cardiovascular Diabetology;2005, Vol. 4, p16
Academic Journal
Accelerated atherosclerosis is one of the major vascular complications of diabetes. Factors including hyperglycemia and hyperinsulinemia may contribute to accelerated vascular disease. Among the several mechanisms proposed to explain the link between hyperglycemia and vascular dysfunction is the hexosamine pathway, where glucose is converted to glucosamine. Although some animal experiments suggest that glucosamine may mediate insulin resistance, it is not clear whether glucosamine is the mediator of vascular complications associated with hyperglycemia. Several processes may contribute to diabetic atherosclerosis including decreased vascular heparin sulfate proteoglycans (HSPG), increased endothelial permeability and increased smooth muscle cell (SMC) proliferation. In this study, we determined the effects of glucose and glucosamine on endothelial cells and SMCs in vitro and on atherosclerosis in apoE null mice. Incubation of endothelial cells with glucosamine, but not glucose, significantly increased matrix HSPG (perlecan) containing heparin-like sequences. Increased HSPG in endothelial cells was associated with decreased protein transport across endothelial cell monolayers and decreased monocyte binding to subendothelial matrix. Glucose increased SMC proliferation, whereas glucosamine significantly inhibited SMC growth. The antiproliferative effect of glucosamine was mediated via induction of perlecan HSPG. We tested if glucosamine affects atherosclerosis development in apoE-null mice. Glucosamine significantly reduced the atherosclerotic lesion in aortic root. (P < 0.05) These data suggest that macrovascular disease associated with hyperglycemia is unlikely due to glucosamine. In fact, glucosamine by increasing HSPG showed atheroprotective effects.


Related Articles

  • High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. Hadaegh, Farzad; Bozorgmanesh, Mohammad Reza; Ghasemi, Asghar; Harati, Hadi; Saadat, Navid; Azizi, Fereidoun // BMC Public Health;2008, Vol. 8 Issue 1, p176 

    Background: To estimate the prevalence of diagnosed and undiagnosed diabetes mellitus, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and combined IFG/IGT in a large urban Iranian population aged ⩾ 20 years. Methods: The study population included 9,489 participants of the...

  • Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study). Yamasaki, Yoshimitsu; Young-Seol Kim; Kawamori, Ryuzo // Cardiovascular Diabetology;2006, Vol. 5, p16 

    Background: Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and safety of antiplatelet therapy in the prevention of atherosclerosis of...

  • PGC-1α Is a Key Regulator of Glucose-Induced Proliferation and Migration in Vascular Smooth Muscle Cells. Lingyun Zhu; Guoxun Sun; Hongjie Zhang; Yan Zhang; Xi Chen; Xiaohong Jiang; Xueyuan Jiang; Stefan Krauss; Junfeng Zhangq; Yang Xiang; Chen-Yu Zhang // PLoS ONE;2009, Vol. 4 Issue 1, p1 

    Background: Atherosclerosis is a complex pathological condition caused by a number of mechanisms including the accelerated proliferation of vascular smooth muscle cells (VSMCs). Diabetes is likely to be an important risk factor for atherosclerosis, as hyperglycemia induces vascular smooth muscle...

  • Changing Metrics for Diabetes Management.  // OB/GYN Clinical Alert;Oct2008 Clinical Briefs in Primary, p19 

    The article cites a study that focuses on the combination of continuous glucose monitoring with Alc levels in subjects with type 1 diabetes, type 2 diabetes, and non-diabetics. The patients underwent continuous glucose monitoring with a Medtronic device that performs serum glucose determinations...

  • Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women. Rossi, Rosario; Cioni, Elena; Nuzzo, Annachiara; Origliani, Giorgia; Modena, Maria Grazia // Diabetes Care;Mar2005, Vol. 28 Issue 3, p702 

    Objective: Both postmenopausal state and diabetes are associated with endothelial dysfunction and are well-known risk factors for atherosclerosis. However, the relationship of endothelium-dependent vasodilation and diabetes has never been prospectively evaluated. This study provided...

  • Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Abke, Sabine; Neumeier, Markus; Weigert, Johanna; Wehrwein, Gabriele; Eggenhofer, Elke; Schäffler, Andreas; Maier, Kevin; Aslanidis, Charalampos; Schölmerich, Jürgen; Buechler, Christa // Cardiovascular Diabetology;2006, Vol. 5, p17 

    Background: Systemic adiponectin is reduced in patients with cardiovascular disease (CVD) and low adiponectin may contribute to the pathogenesis of atherosclerosis. However, circulating adiponectin is elevated in type 1 diabetes (T1D) patients, who have also a higher incidence to develop CVD....

  • Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Ehlermann, Philipp; Eggers, Kai; Bierhaus, Angelika; Most, Patrick; Weichenhan, Dieter; Greten, Johannes; Nawroth, Peter P.; Katus, Hugo A.; Remppis, Andrew // Cardiovascular Diabetology;2006, Vol. 5, p6 

    Background: Atherosclerosis is an inflammatory disease in which a perpetuated activation of NFkappaB via the RAGE (receptor for advanced glycation end products)-MAPK signalling pathway may play an important pathogenetic role. As recently S100 proteins have been identified as ligands of RAGE, we...

  • Early Growth in Offspring of Diabetic Mothers. Touger, Leslie; Looker, Helen C.; Krakoff, Jonathan; Lindsay, Robert S.; Cook, Valerie; Knowler, William C. // Diabetes Care;Mar2005, Vol. 28 Issue 3, p585 

    OBJECTIVE -- By age 5 years, offspring of diabetic mothers (ODMs) are heavier and have altered glucose metabolism compared with offspring of mothers without diabetes (non-DMs). This study evaluates the growth pattern of ODMs before the age of 5 years. RESEARCH DESIGN AND METHODS --...

  • Diabetes, Glucose, Insulin, and Heart Rate Variability. Schroeder, Emily B.; Chambless, Lloyd E.; Duanping Liao; Prineas, Ronald J.; Evans, Gregory W.; Rosamond, Wayne D.; Heiss, Gerardo // Diabetes Care;Mar2005, Vol. 28 Issue 3, p668 

    OBJECTIVE -- To describe the progression of autonomic impairment among individuals with diabetes and pre-diabetic metabolic impairments. RESEARCH DESIGN AND METHODS -- We investigated the consequence of diabetes and pre-diabetic metabolic impairments on the 9-year change in heart rate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics